These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8347147)

  • 21. Resolution of 9-(c-4,t-5-bishydroxymethylcyclopent-2-en-r-1-yl)-9H-adenine and selective inhibition of human immunodeficiency virus by the (-) enantiomer.
    Katagiri N; Shiraishi T; Sato H; Toyota A; Kaneko C; Yusa K; Oh-hara T; Tsuruo T
    Biochem Biophys Res Commun; 1992 Apr; 184(1):154-9. PubMed ID: 1567421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems.
    Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E
    Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of human immunodeficiency virus in vitro by gossypol.
    Polsky B; Segal SJ; Baron PA; Gold JW; Ueno H; Armstrong D
    Contraception; 1989 Jun; 39(6):579-87. PubMed ID: 2473865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
    Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
    Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of gossypol on the cell cycle phases in T-47D human breast cancer cells.
    Thomas M; von Hagen V; Moustafa Y; Montmasson MP; Monet JD
    Anticancer Res; 1991; 11(4):1469-75. PubMed ID: 1746904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity studies on gossypol in tumor cell lines.
    Shelley MD; Hartley L; Groundwater PW; Fish RG
    Anticancer Drugs; 2000 Mar; 11(3):209-16. PubMed ID: 10831280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines.
    Blackstaffe L; Shelley MD; Fish RG
    Melanoma Res; 1997 Oct; 7(5):364-72. PubMed ID: 9429219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
    Qiu YL; Hempel A; Camerman N; Camerman A; Geiser F; Ptak RG; Breitenbach JM; Kira T; Li L; Gullen E; Cheng YC; Drach JC; Zemlicka J
    J Med Chem; 1998 Dec; 41(26):5257-64. PubMed ID: 9857093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
    Prochaska HJ; Rubinson L; Yeh Y; Baron P; Polsky B
    Mol Pharmacol; 1994 May; 45(5):916-21. PubMed ID: 8190108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomer.
    Vince R; Brownell J
    Biochem Biophys Res Commun; 1990 May; 168(3):912-6. PubMed ID: 2346492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and cytotoxicity of gossypol related compounds.
    Dao VT; Gaspard C; Mayer M; Werner GH; Nguyen SN; Michelot RJ
    Eur J Med Chem; 2000 Sep; 35(9):805-13. PubMed ID: 11006482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of the antiviral activity of acyclic nucleosides carrying fluorine and sulfur substituents.
    Bravo P; Resnati G; Viani F; De Montis A; Corrias S; La Colla P
    Farmaco; 1993 Aug; 48(8):1113-20. PubMed ID: 8216673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in gossypol derivatives and analogs: a chemistry and biology view.
    Lu Y; Li J; Dong CE; Huang J; Zhou HB; Wang W
    Future Med Chem; 2017 Jul; 9(11):1243-1275. PubMed ID: 28722469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gossypol: prototype of inhibitors targeted to dinucleotide folds.
    Vander Jagt DL; Deck LM; Royer RE
    Curr Med Chem; 2000 Apr; 7(4):479-98. PubMed ID: 10702620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
    Wei J; Rega MF; Kitada S; Yuan H; Zhai D; Risbood P; Seltzman HH; Twine CE; Reed JC; Pellecchia M
    Cancer Lett; 2009 Jan; 273(1):107-13. PubMed ID: 18782651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.